Etiology and pathophysiology of new-onset heart failure: Evaluation by myocardial perfusion imaging

Journal of Nuclear Cardiology

Volumn 16, Issue 1, 2009, Pages 82-91

  Soman, Prem ^a   Lahiri, Avijit ^b   Mieres, Jennifer H ^c   Calnon, Dennis A ^d   Wolinsky, David ^e   Beller, George A ^f   Sias, Tina ^g   Burnham, Kenneth ^h   Conway, Laurence ⁱ   McCullough, Peter A ^j   Daher, Edouard ^k   Walsh, Mary N ^l   Wight, Joseph ^m   Heller, Gary V ⁿ   Udelson, James E ⁱ  

^a PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^b WELLINGTON HOSPITAL   (United Kingdom)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MidWest Cardiology Research Foundation   (United States)

^e Albany Associates in Cardiology   (United States)

^f UNIVERSITY OF VIRGINIA   (United States)

^g MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h Cardiology Associates of Mobile   (United States)

ⁱ TUFTS UNIVERSITY   (United States)

^j WILLIAM BEAUMONT HOSPITAL   (United States)

^k WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l Care Group   (United States)

^m Maine Cardiology Associates   (United States)

ⁿ UNIVERSITY OF CONNECTICUT   (United States)

more..

Author keywords

Gated SPECT; Heart failure; Myocardial perfusion imaging: SPECT; Sestamibi

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; DISEASE SEVERITY; EXERCISE TEST; FEMALE; GATED IMAGING; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REST; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTOLIC BLOOD PRESSURE; COMORBIDITY; HEART LEFT VENTRICLE FUNCTION; INCIDENCE; METHODOLOGY; MIDDLE AGED; RISK ASSESSMENT; RISK FACTOR; SCINTISCANNING; STATISTICS; UNITED KINGDOM; UNITED STATES;

COMORBIDITY; FEMALE; GREAT BRITAIN; HEART FAILURE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; RISK ASSESSMENT; RISK FACTORS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; UNITED STATES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 67649948209     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12350-008-9010-8     Document Type: Article

References (20)

1. Gheorghiade M, Bonow RO. Chronic heart failure in the United States: A manifestation of coronary artery disease. Circulation 1998;97:282-9.
2. Felker GM, Shaw LK, O'Connor CM. A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol 2002;39:210-8.
3. Bulkley BH, Hutchins GM, Bailey I, Strauss HW, Pitt B. Thallium 201 imaging and gated cardiac blood pool scans in patients with ischemic and idiopathic congestive cardiomyopathy. A clinical and pathologic study. Circulation 1977;55:753-60.
4. Dunn RF, Uren RF, Sadick N, Bautovich G, McLaughlin A, Hiroe M, et al. Comparison of thallium-201 scanning in idiopathic dilated cardiomyopathy and severe coronary artery disease. Circulation 1982;66:804-10.
5. Saltissi S, Hockings B, Croft DN, Webb-Peploe MM. Thallium-201 myocardial imaging in patients with dilated and ischaemic cardiomyopathy. Br Heart J 1981;46:290-5.
6. Tauberg SG, Orie JE, Bartlett BE, Cottington EM, Flores AR. Usefulness of thallium-201 for distinction of ischemic from idiopathic dilated cardiomyopathy. Am J Cardiol 1993;71:674-80.
7. Chikamori T, Doi YL, Yonezawa Y, Yamada M, Seo H, Ozawa T. Value of dipyridamole thallium-201 imaging in noninvasive differentiation of idiopathic dilated cardiomyopathy from coronary artery disease with left ventricular dysfunction. Am J Cardiol 1992;69:650-3.
8. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: The Framingham study. N Engl J Med 1971;285:1441-6.
9. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539-42.
10. Hachamovitch R, Berman DS, Kiat H, Cohen I, Cabico JA, Friedman J, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: Incremental prognostic value and use in risk stratification. Circulation 1996;93:905-14.
11. Mosteller RD. Simplified calculation of body-surface area. N Engl J Med 1987;317:1098.
12. Di B, Pozzi C, Cavallini MC, Innocenti F, Baldereschi G, De A, et al. The diagnosis of heart failure in the community. Comparative validation of four sets of criteria in unselected older adults: The ICARe Dicomano Study. J Am Coll Cardiol 2004;44:1601-8.
13. Schellenbaum GD, Rea TD, Heckbert SR, Smith NL, Lumley T, Roger VL, et al. Survival associated with two sets of diagnostic criteria for congestive heart failure. Am J Epidemiol 2004;160:628-35.
14. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: A meta-analysis. J Am Coll Cardiol 2002;39:1151-8.
15. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult-summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing committee to update the 2001 guidelines for the evaluation and management of heart failure): Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation 2005;112:1825-52.
16. Cleland JG, Pennell DJ, Ray SG, Coats AJ, Macfarlane PW, Murray GD, et al. Carvedilol hm. Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): Randomised controlled trial. Lancet 2003;362:14-21.
17. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 guidelines for the clinical use of cardiac radionuclide imaging). Circulation 2003;108:1404-18.
18. Danias PG, Papaioannou GI, Ahlberg AW, O'Sullivan DM, Mann A, Boden WE, et al. Usefulness of electrocardiographic-gated stress technetium-99m sestamibi single-photon emission computed tomography to differentiate ischemic from nonischemic cardiomyopathy. Am J Cardiol 2004;94:14-9.
19. McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003;108:54-9.
20. Uretsky BF, Thygesen K, Armstrong PW, Cleland JG, Horowitz JD, Massie BM, et al. Acute coronary findings at autopsy in heart failure patients with sudden death: Results from the Assessment of Treatment with Lisinopril and Survival (ATLAS) trial. Circulation 2000;102:611-6.